Nobel Laureate J. Michael Bishop, Who Found Cancer's Genetic Echoes, Passes at 90
Nobel Prize winner J. Michael Bishop died March 20 2026 at 90. His work found cancer's genetic causes, changing how doctors treat it.
#JMichaelBishop, #CancerResearch, #NobelPrize, #Genetics, #MedicalPioneer
https://newsletter.tf/nobel-winner-j-michael-bishop-dies-at-90/
Nobel winner J. Michael Bishop, who found how genes cause cancer, has died at 90. This discovery changed cancer treatment.
#JMichaelBishop, #CancerResearch, #NobelPrize, #Genetics, #MedicalPioneer
https://newsletter.tf/nobel-winner-j-michael-bishop-dies-at-90/
Endoscopic Treatment Colorectal Cancer Advances Come at a Critical Time, Particularly as Colorectal Cancer Has Become the Leading Cause of Cancer Deaths in Those under 50
https://orbitnewshub.com/endoscopic-treatment-colorectal-cancer/
#HealthNews #ColorectalCancer #MedicalBreakthrough #CancerResearch #OrbitNewsHub #EarlyDetection
GSI/FAIR and #THM are joining forces for cancer treatment! 🤝 Together, we are advancing #ParticleTherapy at MIT Marburg and worldwide.
Our focus: #FLASHRadiotherapy ⚡ (high radiation doses delivered in milliseconds). We are investigating the underlying #Radiochemistry and new application techniques to translate this approach from #BasicResearch into clinical use.
#Medicine #CancerResearch #Darmstadt #Marburg #Science
https://www.gsi.de/en/start/news/details/2026/03/26/zusammenarbeit-thm
The Technical University of Applied Sciences Mittelhessen (THM) and GSI/FAIR in Darmstadt intend to collaborate more closely in the field of particle therapy. A corresponding collaboration agreement was recently signed by both partners. The goal is to improve particle therapy both for the Marburg Ion Beam Therapy Center (MIT) and centers worldwide, as well as to support translational and basic research like it is conducted at the GSI/FAIR accelerator facilities.
🔬Svelato il mistero delle recidive nei tumori polmonari. Un passo avanti nella ricerca. #CancerResearch #HealthInnovation
🔗 https://www.tomshw.it/scienze/ecco-perche-il-tumore-al-polmone-ritorna-2026-03-26
Discover the latest in glioblastoma care, from standard surgery to 2026 breakthroughs like DCVax-L, CAR-T cell therapy, and Tumor Treating Fields (TTF).
https://www.nasseej.net/blogs/299841/5-Common-Questions-About-Glioblastoma-Treatment-Options
#Glioblastoma #GBM #BrainCancer #CancerResearch #Immunotherapy2026 #NeuroOncology #BeatCancer
Job Alert
Biostatistician
Deadline: 2026-04-14
Location: Germany - Heidelberg
https://www.academiceurope.com/ads/biostatistician/
#hiring #Biostatistics #DataScience #Omics #CancerResearch #ClinicalResearch #mathematics #statistics
If smoking was the cancer villain of the 20th century, eating ultra-processed food may be its 21st-century counterpart Prof Devi Sridhar is chair of global public health at the University of Edinburgh Cancer used to be seen as part of ageing: something that mainly afflicted people over the age of 60 or 70. But although it is still true that the majority of new cancer diagnoses affect the over-70s, the pattern is changing in subtle ways. Some cancers are increasingly found in younger people. Take colorectal (bowel) cancer: while rates have declined in those over 60, data shows a sharp increase in many developed countries among people under 50, in what’s called early-onset disease. Prof Devi Sridhar is chair of global public health at the University of Edinburgh Continue reading...
NewsletterTF
Biohacking Pathway
Orbit News Hub
universeinthelab_en
Tom's Hardware Italia
MrMed : Online Pharmacy
Academic Europe
Opinion | The Guardian US
purescience_news